To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.
Latest Action
Placed on the Union Calendar, Calendar No. 544.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This bill proposes an amendment to title 38 of the United States Code, directing the Secretary of Veterans Affairs to report on whether certain psychedelic drugs will be included in the Department of Veterans Affairs (VA) formulary. The bill does not specify which psychedelic drugs or the criteria for inclusion but focuses on requiring a formal report from the Secretary. The bill was introduced in the House during the 118th Congress and was placed on the Union Calendar but ultimately failed or expired without further legislative action.
The bill sought to require the VA Secretary to report on the potential inclusion of certain psychedelic drugs in the VA formulary but did not advance beyond being placed on the calendar and eventually expired.
- Amends title 38 of the U.S. Code related to veterans' benefits and health care.
- Directs the Secretary of Veterans Affairs to report on the inclusion of certain psychedelic drugs in the VA formulary.
- The bill was placed on the Union Calendar but failed or expired without further action.
['Veterans potentially receiving new treatment options through the VA health care system', 'Department of Veterans Affairs as the implementing agency', 'Healthcare providers within the VA system']
['Lack of detailed criteria or definitions for which psychedelic drugs are considered', 'Potential challenges in implementation and oversight of new drug formulary inclusions', 'Unclear cost implications for the VA health care system', 'No specified timeline or enforcement mechanism for the required report']
The bill was introduced in the House during the 118th Congress and placed on the Union Calendar, indicating it was scheduled for consideration but did not progress to a vote. It falls within the policy area of Armed Forces and National Security, reflecting ongoing legislative interest in veterans' health care and emerging treatment modalities. The bill ultimately failed or expired, indicating it did not receive sufficient legislative support or prioritization.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased research and evaluation of psychedelic drugs within the VA health system if the report leads to further legislative or administrative action.', "Possible influence on broader federal drug policy discussions related to veterans' health care.", "Impact on veterans' access to alternative or emerging treatments depending on future policy decisions."]
Transparency considerations include the lack of detailed bill text and absence of a formal summary, limiting public understanding of the bill's full scope. Oversight challenges may arise from the vague reporting requirements and undefined drug categories. Monitoring the implementation of any future related legislation will be important to ensure clarity and accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.